We spoke to Dr Kazem Rahimi (Oxford University, Oxford, UK) about the Blood Pressure Lowering Treatment Trialists Collaboration (BPLTTC) and their recent study examining blood pressure lowering to prevent cardiovascular events.Â
Questions
- Could you tell us a little about the Blood Pressure Lowering Treatment Trialists Collaboration (BPLTTC) and its objectives? (0.13)
- Could you give us an overview of the aims and design of the Blood Pressure Lowering for Prevention of Cardiovascular Events across Different Levels of Blood Pressure study? (0.53)
- What were the findings of this study? (1.44)
- What factors should be considered when prescribing blood pressure-lowering medication? (2.32)
- What future studies are planned? (3.48)
Speaker disclosures: Dr Kazem Rahimi has received funding from British Heart Foundation, NIHR Biomedical Research Centre and Oxford Martin School, University of Oxford.
Support: Commissioned, edited and funded by Touch Medical Media.
Filmed during a remote video call with Dr Kazem Rahimi, September 2020.